Abstract
Duplication within the chromosome 17p11.2 (CMT1Adup), peripheral myelin protein 22 (PMP22), myelin protein zero (MPZ) and gap junction β1-protein (GJB1) gene mutations are frequent causes of the Charcot-Marie-Tooth disease (CMT). A large number of mutations in these genes are listed in databases. Sequence variants identified in patients are frequently reported as mutations without further evaluation. We analyzed 250 consecutively recruited unrelated Austrian CMT patients for CMT1Adup by microsatellite marker typing, real-time PCR or MLPA, and found 79 duplications (31.6%). The coding regions of the PMP22, MPZ and GJB1 genes were analyzed by direct sequencing in the remaining patients; 28 patients showed mutations, 14 of which were novel. We scored the pathogenicity of novel missense mutations by segregation studies and by their exclusion in control samples. Our comprehensive literature study found that up to 60% of the reported mutations in these genes had not been evaluated regarding their pathogenicity, and the PANTHER bioinformatics tool was used to score novel and published missense variants. The PANTHER program scored known polymorphisms as such, but scored ∼82–88% only of the published and novel mutations as most likely deleterious. Mutations associated with axonal CMT were less likely to be classified as deleterious, and the PMP22 S72L mutation repeatedly associated with severe CMT was classified as a polymorphism using default parameters. Our data suggest that this in silico analysis tool could be useful for assessing the functional impact of DNA variations only as a complementary approach. The CMT1Adup, GJB1, MPZ and PMP22 mutation frequencies were in the range of those described in other CMT patient collectives with different ethnical backgrounds.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Lupski JR, Garcia CA : Charcot-Marie-Tooth peripheral neurophathies and related disorders; in Scriver CR, Beaudet AL, Sly W, Valle D (eds): The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2001, pp 5759–5788.
Harding AE, Thomas PK : The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 1980; 103: 259–280.
Dyck PJ, Lambert EH : Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol 1968; 18: 603–618.
Kaku DA, Parry GJ, Malamut R, Lupski JR, Garcia CA : Nerve conduction studies in Charcot-Marie-Tooth polyneuropathy associated with a segmental duplication of chromosome 17. Neurology 1993; 43: 1806–1808.
Davis CJ, Bradley WG, Madrid R : The peroneal muscular atrophy syndrome: clinical, genetic, electrophysiological and nerve biopsy studies. I. Clinical, genetic and electrophysiological findings and classification. J Genet Hum 1978; 26: 311–349.
Nelis E, Van Broeckhoven C, De Jonghe P et al: Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet 1996; 4: 25–33.
Szigeti K, Nelis E, Lupski JR : Molecular diagnostics of Charcot-Marie-Tooth disease and related peripheral neuropathies. Neuromolecular Med 2006; 8: 243–254.
Shy ME, Jani A, Krajewski K et al: Phenotypic clustering in MPZ mutations. Brain 2004; 127: 371–384.
Marrosu MG, Vaccargiu S, Marrosu G, Vannelli A, Cianchetti C, Muntoni F : Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurology 1998; 50: 1397–1401.
Nelis E, Haites N, Van Broeckhoven C : Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies. Hum Mutat 1999; 13: 11–28.
Mi H, Guo N, Kejariwal A, Thomas PD : PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways. Nucleic Acids Res 2007; 35: D247–D252.
Badano JL, Inoue K, Katsanis N, Lupski JR : New polymorphic short tandem repeats for PCR-based Charcot-Marie-Tooth disease type 1A duplication diagnosis. Clin Chem 2001; 47: 838–843.
Hayasaka K, Nanao K, Tahara M et al: Isolation and sequence determination of cDNA encoding the major structural protein of human peripheral myelin. Biochem Biophys Res Commun 1991; 180: 515–518.
Floroskufi P, Panas M, Karadima G, Vassilopoulos D : New mutation of the MPZ gene in a family with the Dejerine-Sottas disease phenotype. Muscle Nerve 2007; 35: 667–669.
Bort S, Nelis E, Timmerman V et al: Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies. Hum Genet 1997; 99: 746–754.
Bone LJ, Deschenes SM, Balice-Gordon RJ, Fischbeck KH, Scherer SS : Connexin32 and X-linked Charcot-Marie-Tooth disease. Neurobiol Dis 1997; 4: 221–230.
Shy ME : Peripheral neuropathies caused by mutations in the myelin protein zero. J Neurol Sci 2006; 242: 55–66.
Brunham LR, Singaraja RR, Pape TD, Kejariwal A, Thomas PD, Hayden MR : Accurate prediction of the functional significance of single nucleotide polymorphisms and mutations in the ABCA1 gene. PLoS Genet 2005; 1: e83.
Nelis E, Holmberg B, Adolfsson R, Holmgren G, van Broeckhoven C : PMP22 Thr(118)Met: recessive CMT1 mutation or polymorphism? Nat Genet 1997; 15: 13–14.
Shy ME, Scavina MT, Clark A et al: T118M PMP22 mutation causes partial loss of function and HNPP-like neuropathy. Ann Neurol 2006; 59: 358–364.
Silander K, Meretoja P, Juvonen V et al: Spectrum of mutations in Finnish patients with Charcot-Marie-Tooth disease and related neuropathies. Hum Mutat 1998; 12: 59–68.
Janssen EA, Kemp S, Hensels GW et al: Connexin32 gene mutations in X-linked dominant Charcot-Marie-Tooth disease (CMTX1). Hum Genet 1997; 99: 501–505.
Wise CA, Garcia CA, Davis SN et al: Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMTIA duplication. Am J Hum Genet 1993; 53: 853–863.
Boerkoel CF, Takashima H, Garcia CA et al: Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann Neurol 2002; 51: 190–201.
Mersiyanova IV, Ismailov SM, Polyakov AV et al: Screening for mutations in the peripheral myelin genes PMP22, MPZ and Cx32 (GJB1) in Russian Charcot-Marie-Tooth neuropathy patients. Hum Mutat 2000; 15: 340–347.
Choi BO, Lee MS, Shin SH et al: Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients. Hum Mutat 2004; 24: 185–186.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)
Supplementary information
Rights and permissions
About this article
Cite this article
Miltenberger-Miltenyi, G., Schwarzbraun, T., Löscher, W. et al. Identification and in silico analysis of 14 novel GJB1, MPZ and PMP22 gene mutations. Eur J Hum Genet 17, 1154–1159 (2009). https://doi.org/10.1038/ejhg.2009.29
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2009.29
